Placebo-Controlled Studies With DPP-4 Inhibition as Add-on to Ongoing Exogenous Insulin Therapy Sitagliptin, vildagliptin, saxagliptin, alogliptin, and linagliptin were also examined when added to on-going therapy with insulin in subjects with type 2 diabetes in 2426 week placebo-controlled studies with a total number of 3,196 subjects [Table 2
indicated that analogs similar to CJC-1295 might be linked to muscle cell hypertrophy, possibly contributing to gains of approximately 2.77 lbs of lean mass over 16 weeks
Off-label means the drug is being prescribed for a condition that it was not originally designed for
These allosteric effects can be modulated through the action of carnitine acetyltransferase (CAT), a mitochondrial isoenzyme that transfers the acetyl groups from acetyl-CoA to carnitine, forming acetylcarnitine
BO International, A-91, Wazirpur, New Delhi- 52